Download PDF
Semin intervent Radiol 2021; 38(03): 382-387
DOI: 10.1055/s-0041-1731406
Clinical Corner

Managing Postembolization Syndrome–Related Pain after Uterine Fibroid Embolization

Patricia Chan
1   Division of Interventional Radiology, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
,
Kirema Garcia-Reyes
1   Division of Interventional Radiology, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
,
Julie Cronan
1   Division of Interventional Radiology, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
,
Janice Newsome
1   Division of Interventional Radiology, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
,
Zachary Bercu
1   Division of Interventional Radiology, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
,
Bill S. Majdalany
1   Division of Interventional Radiology, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
,
Neil Resnick
1   Division of Interventional Radiology, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
,
Judy Gichoya
1   Division of Interventional Radiology, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
,
Nima Kokabi
1   Division of Interventional Radiology, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Uterine fibroids are the most common neoplasm affecting women, occurring in more than 70% of women prior to menopause. Of that 70%, 25% have symptoms severe enough to warrant treatment.[1] Symptoms range from abnormal uterine bleeding, bulk symptoms with urinary and bowel incontinence, dyspareunia, infertility, and debilitating chronic pain.[2]

Since its introduction in 1995, uterine artery embolization (UAE) has evolved into a well-established, safe, and effective minimally invasive, uterine-sparing procedure for the treatment of symptomatic uterine fibroids.[3] [4] [5] Annually, greater than 25,000 UAE procedures are performed worldwide.[6] Despite its successes, a persistent challenge and impediment to more widespread use of UAE has been management of postprocedure pain as a result of postembolization syndrome (PES). Inadequate pain control is the most common indication for admission and readmission.[7] Predicting the degree of PES is challenging. The range of severity may vary based on intrinsic patient factors, fibroid size and location, imaging characteristics, or preprocedural symptoms.[8] New techniques and pain regimens can be applied to manage symptoms and significantly improve patient satisfaction.

The objective of this review is to discuss pain management options after UAE by summarizing the current available literature.



Publication History

Article published online:
10 August 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG 2017; 124 (10) 1501-1512
    CrossrefPubMedGoogle Scholar
  • 2 Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health 2012; 12 (01) 6
    CrossrefPubMedGoogle Scholar
  • 3 Lampmann LE, Lohle PN, Smeets A. et al. Pain management during uterine artery embolization for symptomatic uterine fibroids. Cardiovasc Intervent Radiol 2007; 30 (04) 809-811
    CrossrefPubMedGoogle Scholar
  • 4 Ravina JH, Herbreteau D, Ciraru-Vigneron N. et al. Arterial embolisation to treat uterine myomata. Lancet 1995; 346 (8976): 671-672
    CrossrefPubMedGoogle Scholar
  • 5 American College of Obstetricians and Gynecologists. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol 2008; 112 (2, Pt 1): 387-400
    CrossrefPubMedGoogle Scholar
  • 6 Keung JJ, Spies JB, Caridi TM. Uterine artery embolization: a review of current concepts. Best Pract Res Clin Obstet Gynaecol 2018; 46: 66-73
    CrossrefPubMedGoogle Scholar
  • 7 Hovsepian DM, Mandava A, Pilgram TK. et al. Comparison of adjunctive use of rofecoxib versus ibuprofen in the management of postoperative pain after uterine artery embolization. J Vasc Interv Radiol 2006; 17 (04) 665-670
    CrossrefPubMedGoogle Scholar
  • 8 Roth AR, Spies JB, Walsh SM, Wood BJ, Gomez-Jorge J, Levy EB. Pain after uterine artery embolization for leiomyomata: can its severity be predicted and does severity predict outcome?. J Vasc Interv Radiol 2000; 11 (08) 1047-1052
    CrossrefPubMedGoogle Scholar
  • 9 Hovsepian DM, Siskin GP, Bonn J. et al; CIRSE Committee, SIR Standards of Practice Committee. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J Vasc Interv Radiol 2004; 15 (06) 535-541
    CrossrefPubMedGoogle Scholar
  • 10 Ganguli S, Faintuch S, Salazar GM, Rabkin DJ. Postembolization syndrome: changes in white blood cell counts immediately after uterine artery embolization. J Vasc Interv Radiol 2008; 19 (03) 443-445
    CrossrefPubMedGoogle Scholar
  • 11 Spencer EB, Stratil P, Mizones H. Clinical and periprocedural pain management for uterine artery embolization. Semin Intervent Radiol 2013; 30 (04) 354-363
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Pasero C, Stannard D. The role of intravenous acetaminophen in acute pain management: a case-illustrated review. Pain Manag Nurs 2012; 13 (02) 107-124
    CrossrefPubMedGoogle Scholar
  • 13 Chaabane S, Hoffman C, Kim G. et al. A prospective, double-blind, randomized controlled study evaluating the effects of two new IV medications, IV acetaminophen and/or IV ibuprofen, on standard of care pain and antiemetic management in uterine fibroid embolization patients. J Vasc Interv Radiol 2017; 28 (02) S47-S48
    CrossrefPubMedGoogle Scholar
  • 14 Bilhim T, Pisco JM. The role of nonsteroidal anti-inflammatory drugs (NSAIDs) in the management of the post-embolization symptoms after uterine artery embolization. Pharmaceuticals (Basel) 2010; 3 (06) 1729-1738
    CrossrefPubMedGoogle Scholar
  • 15 Siskin GP, Stainken BF, Dowling K, Meo P, Ahn J, Dolen EG. Outpatient uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients. J Vasc Interv Radiol 2000; 11 (03) 305-311
    CrossrefPubMedGoogle Scholar
  • 16 Hansen RN, Pham AT, Boing EA, Lovelace B, Wan GJ, Urman RD. Reduced length of stay and hospitalization costs among inpatient hysterectomy patients with postoperative pain management including IV versus oral acetaminophen. PLoS One 2018; 13 (09) e0203746-e0203746
    CrossrefPubMedGoogle Scholar
  • 17 Mahajan L, Mittal V, Gupta R, Chhabra H, Vidhan J, Kaur A. Study to compare the effect of oral, rectal, and intravenous infusion of paracetamol for postoperative analgesia in women undergoing cesarean section under spinal anesthesia. Anesth Essays Res 2017; 11 (03) 594-598
    CrossrefPubMedGoogle Scholar
  • 18 Johnson RJ, Nguyen DK, Acosta JM, O'Brien AL, Doyle PD, Medina-Rivera G. Intravenous versus oral acetaminophen in ambulatory surgical center laparoscopic cholecystectomies: a retrospective analysis. P&T 2019; 44 (06) 359-363
    PubMedGoogle Scholar
  • 19 Raffa RB. Pharmacology of oral combination analgesics: rational therapy for pain. J Clin Pharm Ther 2001; 26 (04) 257-264
    CrossrefPubMedGoogle Scholar
  • 20 Bresalier RS, Sandler RS, Quan H. et al; Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005; 352 (11) 1092-1102
    CrossrefPubMedGoogle Scholar
  • 21 Nissen SE, Yeomans ND, Solomon DH. et al; PRECISION Trial Investigators. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2016; 375 (26) 2519-2529
    CrossrefPubMedGoogle Scholar
  • 22 Pisco JM, Bilhim T, Duarte M, Santos D. Management of uterine artery embolization for fibroids as an outpatient procedure. J Vasc Interv Radiol 2009; 20 (06) 730-735
    CrossrefPubMedGoogle Scholar
  • 23 Freire GMG, Cavalcante RN, Motta-Leal-Filho JM. et al. Controlled-release oxycodone improves pain management after uterine artery embolisation for symptomatic fibroids. Clin Radiol 2017; 72 (05) 428.e1-428.e5
    CrossrefPubMedGoogle Scholar
  • 24 Saibudeen A, Makris GC, Elzein A. et al. Pain management protocols during uterine fibroid embolisation: a systematic review of the evidence. Cardiovasc Intervent Radiol 2019; 42 (12) 1663-1677
    CrossrefPubMedGoogle Scholar
  • 25 Waldron NH, Jones CA, Gan TJ, Allen TK, Habib AS. Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis. Br J Anaesth 2013; 110 (02) 191-200
    CrossrefPubMedGoogle Scholar
  • 26 Wang M, Kohi MP. The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy of single-dose dexamethasone in reducing post-embolization syndrome in patients undergoing uterine artery embolization. Contemp Clin Trials Commun 2018; 12: 85-89
    CrossrefPubMedGoogle Scholar
  • 27 Kim SY, Chang CH, Lee JS, Kim YJ, Kim MD, Han DW. Comparison of the efficacy of dexmedetomidine plus fentanyl patient-controlled analgesia with fentanyl patient-controlled analgesia for pain control in uterine artery embolization for symptomatic fibroid tumors or adenomyosis: a prospective, randomized study. J Vasc Interv Radiol 2013; 24 (06) 779-786
    CrossrefPubMedGoogle Scholar
  • 28 Raldi FV, Nascimento RD, Sato FRL, Santos LM, Amorim JBO, de Moraes MB. Evaluation of the impact of preoperative use of dexamethasone and cyclobenzaprine in surgical extraction of lower third molars on trismus by electromyographic analysis. Oral Maxillofac Surg 2019; 23 (04) 395-405
    CrossrefPubMedGoogle Scholar
  • 29 Hwang SK. Advances in the treatment of chronic pelvic pain: a multidisciplinary approach to treatment. Mo Med 2017; 114 (01) 47-51
    PubMedGoogle Scholar
  • 30 Rasuli P, Jolly EE, Hammond I. et al. Superior hypogastric nerve block for pain control in outpatient uterine artery embolization. J Vasc Interv Radiol 2004; 15 (12) 1423-1429
    CrossrefPubMedGoogle Scholar
  • 31 Park PJ, Kokabi N, Nadendla P, Lindsey T, Dariushnia SR. Efficacy of intraprocedural superior hypogastric nerve block in reduction of postuterine artery embolization narcotic analgesia use. Can Assoc Radiol J 2020; 71 (01) 75-80
    CrossrefPubMedGoogle Scholar
  • 32 Pereira K, Morel-Ovalle LM, Wiemken TL. et al. Intraprocedural superior hypogastric nerve block allows same-day discharge following uterine artery embolization. J Vasc Interv Radiol 2020; 31 (03) 388-392
    CrossrefPubMedGoogle Scholar
  • 33 Stewart JK, Patetta MA, Burke CT. Superior hypogastric nerve block for pain control after uterine artery embolization: effect of addition of steroids on analgesia. J Vasc Interv Radiol 2020; 31 (06) 1005-1009.e1
    CrossrefPubMedGoogle Scholar
  • 34 Hoffman C, Yarosh C, Boyd E. et al. Superior hypogastric nerve block in uterine fibroid embolization patients with radial artery access: vascular considerations, anesthetic choices, and rescue options. J Vasc Interv Radiol 2018; 29 (05) 745-747
    CrossrefPubMedGoogle Scholar
  • 35 Noel-Lamy M, Tan KT, Simons ME, Sniderman KW, Mironov O, Rajan DK. Intraarterial lidocaine for pain control in uterine artery embolization: a prospective, randomized study. J Vasc Interv Radiol 2017; 28 (01) 16-22
    CrossrefPubMedGoogle Scholar
  • 36 Duvnjak S, Andersen PE. Intra-arterial lidocaine administration during uterine fibroid embolization to reduce the immediate postoperative pain: a prospective randomized study. CVIR Endovasc 2020; 3 (01) 10
    CrossrefPubMedGoogle Scholar
  • 37 Katsumori T, Miura H, Yoshikawa T, Seri S, Kotera Y, Asato A. Intra-arterial lidocaine administration for anesthesia after uterine artery embolization with trisacryl gelatin microspheres for leiomyoma. J Vasc Interv Radiol 2020; 31 (01) 114-120
    CrossrefPubMedGoogle Scholar
  • 38 Caridi T. Intra-arterial lidocaine is not found to be effective for reducing pain after uterine fibroid embolization in a retrospective study: now what?. J Vasc Interv Radiol 2020; 31 (01) 121-122
    CrossrefPubMedGoogle Scholar
  • 39 Keyoung JA, Levy EB, Roth AR, Gomez-Jorge J, Chang TC, Spies JB. Intraarterial lidocaine for pain control after uterine artery embolization for leiomyomata. J Vasc Interv Radiol 2001; 12 (09) 1065-1069
    CrossrefPubMedGoogle Scholar
  • 40 Resnick NJ, Kim E, Patel RS, Lookstein RA, Nowakowski FS, Fischman AM. Uterine artery embolization using a transradial approach: initial experience and technique. J Vasc Interv Radiol 2014; 25 (03) 443-447
    CrossrefPubMedGoogle Scholar
  • 41 Nakhaei M, Mojtahedi A, Faintuch S, Sarwar A, Brook OR. Transradial and transfemoral uterine fibroid embolization comparative study: technical and clinical outcomes. J Vasc Interv Radiol 2020; 31 (01) 123-129
    CrossrefPubMedGoogle Scholar
  • 42 Liu LB, Cedillo MA, Bishay V. et al. Patient experience and preference in transradial versus transfemoral access during transarterial radioembolization: a randomized single-center trial. J Vasc Interv Radiol 2019; 30 (03) 414-420
    CrossrefPubMedGoogle Scholar
  • 43 Fischman AM, Swinburne NC, Patel RS. A technical guide describing the use of transradial access technique for endovascular interventions. Tech Vasc Interv Radiol 2015; 18 (02) 58-65
    CrossrefPubMedGoogle Scholar